natgillin/translations-raw huggingface dataset:
(1 time), dag 1-3; vinkistin 1,3 mg/m2 i.v., dag 1, 8, 15, 21; prednisolon 60 
(1 h), days 1-3; Vincristine 1.3 mg/m2 i.v., days 1, 8, 15, 21;
Crospovidon Magnesiumstearat Kolloid vandfri silica 
Crospovidone Magnesium stearate Silica colloidal, anhydrous
Dosering ved HES/CEL Den anbefalede dosis af Imatinib Teva er 100 mg/dag til voksne patienter med HES/CEL. 
Posology for HES/CEL The recommended dose of Imatinib Teva is 100 mg/day for adult patients with HES/CEL.
Lægen vil fortælle dig, hvor mange Imatinib Teva-kapsler, du skal give dit barn. 
The doctor will tell you how many capsules of Imatinib Teva to give to your child.
Remissionsinduktion 
Remission induction
(24 timer), dag 4; DEX 40 mg/dag på dag 1-4 og 11-14, supplerende med MTX 1 g/m2 i.v. 
DEX 40 mg/day on days 1-4 and 11-14, alternated with MTX 1 g/m2 i.v.
- Hvis du er bekymret for din frugtbarhed, mens du tager Imatinib Teva, skal du kontakte din læge. 
- Patients who are concerned about their fertility while taking Imatinib Teva are advised to consult with their doctor.
eller p.o. q6h x 6 doser)iii: dag 2, 3, 16, og 17 
doses)iii: days 2, 3, 16, and 17
Lægen vil fortælle dig, hvor mange Imatinib Teva-tabletter, du skal give dit barn. 
The doctor will tell you how many tablets of Imatinib Teva to give to your child.
Ved andre doser end 400 mg og 800 mg (se anbefalede doser nedenfor) er en 100 mg filmovertrukken tablet tilgængelig. 
For doses other than 400 mg and 800 mg (see dose recommendation below) a 100 mg film-coated tablet is available.
Den anbefalede dosis af Imatinib Teva er 400 mg/dag til voksne patienter med CML i kronisk fase. 
The recommended dosage of Imatinib Teva is 400 mg/day for adult patients in chronic phase CML.
Hvis du ved et uheld har indtaget for mange kapsler, skal du kontakte din læge med det samme. 
If you take more Imatinib Teva than you should If you have accidentally taken too many capsules, talk to your doctor straight away.
Dosis er 800 mg pr. dag (2 tabletter), som skal tages som 1 tablet om morgenen og 1 tablet om aftenen. 
The dose is 800 mg per day (2 tablets), to be taken as 1 tablet in the morning and a second tablet in the evening.
Mørk gul til brunlig-orange rund filmovertrukken tablet med delekærv på den ene side. 
Dark yellow to brownish orange round film-coated tablets with a score line on one side.
Tabletten er indgraveret med ”IT” på den ene side af delekærven og ”1” på den anden side af delekærven. 
The tablet is debossed with “IT” and “1” at each side of the score line.
Benigne, maligne og uspecificerede tumorer (inkl. 
Neoplasm benign, malignant and unspecified (including cysts and polyps) Rare
Meget almindelig 
Investigations Very common
Tabletten er indgraveret med ”IT” på den ene side af delekærven og ”4” på den anden side af delekærven. 
The tablet is debossed with “IT” and “4” at each side of the score line.
Dosering ved DFSP Den anbefalede dosis af Imatinib Teva er 800 mg/dag til voksne patienter med DSFP. 
Posology for DFSP The recommended dose of Imatinib Teva is 800 mg/day for adult patients with DFSP.
Dosis er 800 mg pr. dag (2 kapsler), som skal tages som 1 kapsel om morgenen og 1 kapsel om aftenen. 
The dose is 800 mg per day (2 capsules), to be taken as 1 capsule in the morning and a second capsule in the evening.
Samtidig anvendelse af imatinib og lægemidler, der inducerer CYP3A4 (f.eks. dexamethason, phenytoin, carbamazepin, rifampicin, phenobarbital eller Hypericum perforatum, også kendt som prikbladet perikum) kan signifikant reducere følsomheden over for imatinib, og dermed potientielt øge risikoen for terapeutisk svigt. 
Concomitant use of imatinib and medicinal products that induce CYP3A4 (e.g. dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital or Hypericum perforatum, also known as St. John's Wort) may significantly reduce exposure to imatinib, potentially increasing the risk of therapeutic failure.
- Øvrige indholdsstoffer: mannitol, crospovidon, magnesiumstearat og kolloid vandfri silica. 
- The other ingredients are mannitol, crospovidone, magnesium stearate and silica colloidal anhydrous.
DEt reproductive system og mammae 
Reproductive system and breast disorders Uncommon
Tabel 4 Kemoterapiregime anvendt i kombination med imatinib Studie ADE10 
Table 4 Chemotherapy regimen used in combination with imatinib
Den anbefalede dosis af Imatinib Teva er 600 mg/dag til voksne patienter i accelereret fase. 
The recommended dosage of Imatinib Teva is 600 mg/day for adult patients in accelerated phase.
Hvis du ved et uheld har indtaget for mange tabletter, skal du kontakte din læge med det samme. 
If you take more Imatinib Teva than you should If you have accidentally taken too many tablets, talk to your doctor straight away.
Der er udført en åben, multicenter fase II-undersøgelse (studie B2225) med henblik på at vurdere Imatinib Teva hos en blandet patientpopulation med livstruende sygdomme forbundet med Abl-, Kiteller PDGFR-proteintyrosinkinaser. 
One open-label, multicentre, phase II clinical trial (study B2225) was conducted testing imatinib in diverse populations of patients suffering from life-threatening diseases associated with Abl, Kit or PDGFR protein tyrosine kinases.
Den anbefalede dosis af Imatinib Teva er 600 mg/dag til voksne patienter i blastkrise. 
The recommended dose of Imatinib Teva is 600 mg/day for adult patients in blast crisis.
Imatinib Teva 400 mg hårde kapsler er ikke-tansperante orange kapsler præget i sort blæk med 7630 på kapselbunden og TEVA på kapseltoppen. 
What Imatinib Teva looks like and contents of the pack Imatinib Teva 400 mg hard capsules are non transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap.
Målorganerne for neoplastiske ændringer var nyrerne, urinblæren, urinrøret, fedtkirtlerne på forhuden og klitoris, tyndtarmen, biskjoldbruskkirtlerne, binyrererne og den ikkekirtellignende del af maven. 
Target organs for neoplastic changes were the kidneys, urinary bladder, urethra, preputial and clitoral gland, small intestine, parathyroid glands, adrenal glands and non-glandular stomach.
Din læge vil fortælle dig, præcis hvor mange Imatinib Teva-tabletter, du skal tage. 
Your doctor will tell you exactly how many tablets of Imatinib Teva to take.
Jernoxid, gul (E 172) Talcum 
Iron oxide yellow (E172) Talc
Pakningsstørrelser indeholdende 60 eller 120 hårde kapsler i blisterpakninger. 
Pack sizes of 60 or 120, hard capsules in blisters.
Der sås 4. grads neutropeni (ANC <0,5 x 109/l) og trombopeni (trombocyttal <10 x 109/l) hos henholdsvis 3,6% og < 1% af patienterne med nydiagnosticeret CML i kronisk fase. 
In newly diagnosed chronic phase CML grade 4 neutropenia (ANC < 0.5 x 109/l) and thrombocytopenia (platelet count < 10 x 109/l) were observed in 3.6% and < 1% of patients, respectively.
Forhøjet serumkreatinin, forhøjet serumkreatinkinase og forhøjet serumlaktatdehydrogenase, forhøjet alkalisk fosfatase 
Blood creatinine increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood alkaline phosphatase increased
600 mg som skal tages som 6 tabletter én gang daglig. 
600 mg to be taken as 6 tablets once a day.
Startdosis er 600 mg, som skal tages som 1 tablet á 400 mg og 2 tabletter á 100 mg eller som halvanden 400 mg tablet én gang daglig. 
The starting dose is 600 mg to be taken as 1 tablet of 400 mg plus 2 tablets of 100 mg or as 1 ½ tablets of 400 mg once a day.
Imatinib Teva 100 mg hårde kapsler er ikke-tansperante orange kapsler præget i sort blæk med 7629 på kapselbunden og TEVA på kapseltoppen. 
What Imatinib Teva looks like and contents of the pack Imatinib Teva 100 mg hard capsules are non transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap.
månedligt i 13 måneder; prednisolon 200 mg oral, 5 dag per måned i 13 måneder Alle behandlingsregimer inkluderer administration af steroider mod CNS profylakse Ara-C: cytosin arabinosid; CP: cyclophosphamid; DEX: dexamethason; MTX: methotrexat; 6MP: 6-mercaptopurin; VM26: teniposid; VCR: vinkristin; IDA: idarubicin; i.v. 
Ara-C: cytosine arabinoside; CP: cyclophosphamide; DEX: dexamethasone; MTX: methotrexate; 6MP: 6-mercaptopurine VM26: Teniposide; VCR: vincristine; IDA: idarubicine; i.v.
DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN 
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 08 January 2013
ANC ≥1,5 x 109/l og trombocytter ≥75 x 109/l. 
1.5 x 109/l and platelets ≥ 75 x 109/l.
Seponer Imatinib Teva indtil ANC ≥ 1,5 x 109/l og trombocytter ≥75 x 109/l. 
Stop imatinib until ANC ≥ 1.5 x 109/l and platelets ≥ 75 x 109/l.
Pakningsstørrelser indeholdende 30x1 eller 90x1 filmovertrukne tabletter i perforeret enkeltdosisblister. 
Pack sizes of 30x1 or 90x1 film-coated tablets in perforated unit dose blisters.
Navn og adresse på fremstillerne ansvarlige for batchfrigivelse 
MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Imatinib Teva 100 mg hårde kapsler findes i pakninger med 60 eller 120 hårde kapsler i blisterpakninger. 
Imatinib Teva 100 mg hard capsules are available in pack sizes of 60 or 120 hard capsules in blisters.
Ikke transparent orange kapsel præget i sort blæk med 7629 på kapselbunden og præget i sort blæk med TEVA på kapseltoppen. 
Non transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap.
mg/m2/dag oral 
Prednisolone 60 mg/m2/day oral
Mørk gul til brunlig-orange aflang filmovertrukken tablet med delekærv på den ene side. 
Dark yellow to brownish orange oblong film-coated tablets with a score line on one side.
Alderen på disse patienter rangerede fra 2 til 16 år, og imatinib blev givet i en dosis på 300 mg/m2 dagligt eller doser, 
The age of these patients ranged from 2 to 16 years and imatinib was given at dose 300 mg/m2 daily or doses ranging from 200 to 400 mg daily.
DEX 10 mg/m2 oral, dag 1-5; CP 200 mg/m2 i.v., dag 3, 4, 5; MTX 12 mg intrathecal, dag 
DEX 10 mg/m2 oral, days 1-5; CP 200 mg/m i.v., days 3, 4, 5; MTX 12 mg intrathecal, day 1
600 mg som skal tages som 6 kapsler én gang daglig. 
600 mg to be taken as 6 capsules once a day.
9/l, myelocytter+metamyelocytter <5% i blod, ingen blaster og promyelocytter i blod, basofile <20%, ingen ekstramedullær påvirkning Cytogenetiske responskriterier: fuldstændig (0% Ph+ metafaser), delvis (1-35%), mindre (3665%) eller minimal (66-95%). 
Major response at 84 months (%) * p<0.001, Fischer's exact test ** molecular response percentages are based on available samples Haematological response criteria (all responses to be confirmed after ≥ 4 weeks): WBC < 10 x 109/l, platelet < 450 x 109/l, myelocyte+metamyelocyte < 5% in blood, no blasts and promyelocytes in blood, basophils < 20%, no extramedullary involvement Cytogenetic response criteria: complete (0% Ph+ metaphases), partial (1-35%), minor (3665%) or minimal (66-95%).
- Tag Imatinib Teva sammen med et måltid. 
When and how to take Imatinib Teva - Take Imatinib Teva with a meal.
Kapslen er fra 19,1 mm til 19,7 mm lang og 6,91 mm bred. 
The length of the capsule is from 19.1 mm to 19.7 mm and the width is 6.91 mm. Imatinib Teva 400 mg hard capsules
Afhængigt af din tilstand er den almindelige startdosis enten 400 mg eller 600 mg: 400 mg som skal tages som én tablet én gang daglig. 
Depending on your condition the usual starting dose is either 400 mg or 600 mg: 400 mg to be taken as 1 tablet once a day,
600 mg som skal tages som én kapsel af 400 mg plus 2 kapsler af 100 mg én gang daglig. 
The starting dose is 600 mg to be taken as 1 capsule of 400 mg plus 2 capsules of 100 mg once a day.
Overordnet var den gennemsnitlige daglige dosis 406 ± 76 mg hos patienter som fik imatinib som førstevalg. 
Overall, in patients receiving first-line imatinib, the average daily dose delivered was 406 ±76 mg.
Din læge vil fortælle dig, præcis hvor mange Imatinib Teva-kapsler, du skal tage. 
Your doctor will tell you exactly how many capsules of Imatinib Teva to take.
Hvis din daglige dosis er 800 mg (2 tabletter), skal du tage én tablet om morgenen og én tablet om aftenen. 
If your daily dose is 800 mg (2 tablets), you should take one tablet in the morning and a second tablet in the evening.
Stop Imatinib Teva indtil 
Stop imatinib until ANC ≥
Pakningsstørrelser indeholdende 30x1 eller 90x1 hårde kapsler i perforeret enkeltdosisblister. 
Pack sizes of 30x1 or 90x1 hard capsules in perforated unit dose blisters.
Dosering til børn bør baseres på legemsoverfladeareal (mg/m2). 
Posology for CML in paediatric patients Dosing for children should be on the basis of body surface area (mg/m2).
Titandioxid (E171) Jernoxid, gul (E 172) Jernoxid, rød (E 172) 
Titanium dioxide (E171) Iron oxide, yellow (E172) Iron oxide, red (E172)
a ANC < 0.5 x 109/l og/eller trombocytter < 10 x 109/l 
a ANC < 0.5 x 109/l and/or platelets < 10 x 109/l
Ikke transparent orange kapsel præget i sort blæk med 7630 på kapselbunden og præget i sort blæk med TEVA på kapseltoppen. 
Non transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap.
Pakningsstørrelser indeholdende 20x1, 60x1, 120x1 eller 180x1 filmovertrukne tabletter i perforeret enkeltdosisblister. 
Pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters.
Imatinib Teva 100 mg hårde kapsler findes i pakninger med 20x1, 60x1, 120x1 eller 180x1 hårde kapsler i perforerede enkeltdosisblisterpakninger. 
Imatinib Teva 100 mg hard capsules are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters.
Imatinib Teva 400 mg hårde kapsler findes i pakninger med 30x1 eller 90x1 hårde kapsler i perforerede enkeltdosisblisterpakninger. 
Imatinib Teva 400 mg hard capsules are available in pack sizes of 30x1 or 90x1 hard capsules in perforated unit dose blisters.
Imatinib Teva 100 mg filmovertrukne tabletter findes i pakninger med 20x1, 60x1, 120x1 eller 180x1 filmovertrukne tabletter i perforerede enkeltdosisblisterpakninger. 
Imatinib Teva 100 mg film-coated tablets are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters.
Pakningsstørrelser indeholdende 20x1, 60x1, 120x1 eller 180x1 hårde kapsler i perforeret enkeltdosisblister. 
Pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters.
Sådan skal du tage Imatinib Teva 
How to take Imatinib Teva
Af disse 117 patienter var 61 positive for FIP1L1-PDGFRα fusionkinase. 
FIP1L1-PDGFRα fusion kinase was identified.
): dag 4 
See section 4
): dag 1-5 
days 1-3;
Dosis kan reduceres ved intolerance (se pkt. 
The dose can be reduced if not tolerated (see section 4.2 and 5.2).
Imatinib Teva 100 mg filmovertrukne tabletter er mørkegule til brun-orange runde filmovertrukne tabletter med delekærv på den ene side. 
What Imatinib Teva looks like and contents of the pack Imatinib Teva 100 mg film-coated tablets are dark yellow to brownish orange round film-coated tablets with a score line on one side.
Imatinib Teva 400 mg hårde kapsler findes i pakninger med 30 eller 90 hårde kapsler i blisterpakninger. 
Imatinib Teva 400 mg hard capsules are available in pack sizes of 30 or 90 hard capsules in blisters.
ANC < 1,0 x 109/l og/eller trombocytter < 50 x 109/l 
ANC < 1.0 x 109/l and/or platelets < 50 x 109/l
Aktive stoffer der kan reducere plasmakoncentrationen af imatinib Stoffer, der inducerer CYP3A4-aktivitet (f.eks. dexamethason, phenytoin, carbamazepin, rifampicin, phenobarbital, fosphenytoin, primidon eller perikon (Hypericum perforatum), kan signifikant reducere følsomheden for Imatinib og dermed potentielt øge risikoen for terapeutisk svigt. 
Active substances that may decrease imatinib plasma concentrations Substances that are inducers of CYP3A4 activity (e.g. dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital, fosphenytoin, primidone or Hypericum perforatum, also known as St. John's Wort) may significantly reduce exposure to imatinib, potentially increasing the risk of therapeutic failure.
DEX (6 mg/m2/dag p.o.): dag 1-5; 29-33 
DEX (6 mg/m2/day PO): days 1-5; 29-33
Imatinib Teva 400 mg filmovertrukne tabletter findes i pakninger med 30x1 eller 90x1 filmovertrukne tabletter i perforerede enkeltdosisblisterpakninger. 
Imatinib Teva 400 mg film-coated tablets are available in pack sizes of 30x1or 90x1 film-coated tablets in perforated unit dose blisters.
Konsolidering blok 2 (3 uger)) 
Consolidation block 2 (3 weeks)
Kapselskallen består af gelatine, titandioxid (E 171), gul jernoxid (E 172) og rød jernoxid (E 172). 
The capsule shell is composed of gelatin, titanium dioxide (E171), iron oxide yellow (E172) and iron oxide red (E172).
Imatinib Teva 400 mg filmovertrukne tabletter er mørkegule til brun-orange runde filmovertrukne tabletter med delekærv på den ene side. 
What Imatinib Teva looks like and contents of the pack Imatinib Teva 400 mg film-coated tablets are dark yellow to brownish orange oblong film-coated tablets with a score line on one side.
Imatinib Teva 400 mg filmovertrukne tabletter Pakningsstørrelser indeholdende 30 eller 90 filmovertrukne tabletter i blisterpakninger. 
Imatinib Teva 400 mg film-coated tablets Pack sizes of 30 or 90 film-coated tablets in blisters.
Imatinib Teva 100 mg filmovertrukne tabletter findes i pakninger med 60 eller 120 filmovertrukne tabletter i blisterpakninger. 
Imatinib Teva 100 mg film-coated tablets are available in pack sizes of 60 or 120 film-coated tablets in blisters.
Major respons n (%) [95% CI] 
Cytogenetic response Major response n (%) [95% CI]
Imatinib Teva 100 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 100 mg imatinib (som mesilat). 
Imatinib Teva 100 mg film-coated tablets Each film-coated tablet contains 100 mg of imatinib (as mesilate).
VCR 2 mg total dose i.v., dag 1, 8, 15, 22; CP 750 mg/m2 i.v., dag 1, 8; prednison 60 mg/m2 oral, dag 1-7, 15-21; IDA 9 mg/m2 oral, dag 1 
VCR 2 mg total dose i.v., days 1, 8, 15, 22; CP 750 mg/m2 i.v., days 1, 8;
Undersøgelser 
diagnosis
Hæmatologisk respons 
Haematological adverse reactions
Hvis din daglige dosis er 800 mg (2 kapsler), skal du tage én kapsel om morgenen og én kapsel om aftenen. 
If your daily dose is 800 mg (2 capsules), you should take one capsule in the morning and a second capsule in the evening.
Imatinib Teva 400 mg hårde kapsler 
Imatinib Teva 400 mg hard capsules
Remission til kronisk fasehronic phase 
Return to chronic phase (RTC)
EU/1/12/808/033 30 hårde kapsler EU/1/12/808/034 30 x 1 hårde kapsler EU/1/12/808/035 90 hårde kapsler EU/1/12/808/036 90 x 1 hårde kapsler EU/1/12/808/037 30 hårde kapsler EU/1/12/808/038 30 x 1 hårde kapsler EU/1/12/808/039 90 hårde kapsler EU/1/12/808/040 90 x 1 hårde kapsler 
EU/1/12/808/033 30 hard capsules EU/1/12/808/034 30 x 1 hard capsules EU/1/12/808/035 90 hard capsules EU/1/12/808/036 90 x 1 hard capsules EU/1/12/808/037 30 hard capsules EU/1/12/808/038 30 x 1 hard capsules EU/1/12/808/039 90 hard capsules EU/1/12/808/040 90 x 1 hard capsules
Anvendelse til børn 
Use in adults
Hvor længe skal du tage Imatinib Teva 
How much Imatinib Teva to take
Imatinib Teva 400 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 400 mg imatinib (som mesilat). 
Imatinib Teva 400 mg film-coated tablets Each film-coated tablet contains 400 mg of imatinib (as mesilate).
• Flåd fra øjet med kløe, rødme og hævelse (betændelse af øjets bindehinde), øget tåreflåd eller sløret syn. 
• Discharge from the eye with itching, redness and swelling (conjunctivitis), watery eyes or having blurred vision.
Imatinib Teva 100 mg hårde kapsler imatinib 
Imatinib Teva 100 mg hard capsules imatinib
Imatinib Teva 400 mg kapsler Hver kapsel indeholder 400 mg imatinib (som mesilat). 
Imatinib Teva 400 mg hard capsules Each hard capsule contains 400 mg of imatinib (as mesilate).
Imatinib Teva 100 mg hårde kapsler 
Imatinib Teva 100 mg hard capsules
Imatinib Teva 400 mg hårde kapsler imatinib 
Imatinib Teva 400 mg hard capsules imatinib
): dag 1 
(1 h) day 1;
DEX 10 mg/m2 oral, dag 6-7, 13-16; VCR 1 mg i.v., dag 7, 14; IDA 8 mg/m2 i.v. 
DEX 10 mg/m2 oral, days 6-7, 13-16; VCR 1 mg i.v., days 7, 14;
EU/1/12/808/021 20 x 1 hårde kapsler EU/1/12/808/022 60 hårde kapsler EU/1/12/808/023 60 x 1 hårde kapsler EU/1/12/808/024 120 hårde kapsler EU/1/12/808/025 120 x 1 hårde kapsler EU/1/12/808/026 180 x 1 hårde kapsler EU/1/12/808/027 20 x 1 hårde kapsler EU/1/12/808/028 60 hårde kapsler EU/1/12/808/029 60 x 1 hårde kapsler EU/1/12/808/030 120 hårde kapsler EU/1/12/808/031 120 x 1 hårde kapsler EU/1/12/808/032 180 x 1 hårde kapsler 
EU/1/12/808/021 20 x 1 hard capsules EU/1/12/808/022 60 hard capsules EU/1/12/808/023 60 x 1 hard capsules EU/1/12/808/024 120 hard capsules EU/1/12/808/025 120 x 1 hard capsules EU/1/12/808/026 180 x 1 hard capsules EU/1/12/808/027 20 x 1 hard capsules EU/1/12/808/028 60 hard capsules EU/1/12/808/029 60 x 1 hard capsules EU/1/12/808/030 120 hard capsules EU/1/12/808/031 120 x 1 hard capsules EU/1/12/808/032 180 x 1 hard capsules
Imatinib Teva 100 mg kapsler Hver kapsel indeholder 100 mg imatinib (som mesilat). 
Imatinib Teva 100 mg hard capsules Each hard capsule contains 100 mg of imatinib (as mesilate).
Imatinib Teva 400 mg filmovertrukne tabletter imatinib 
Imatinib Teva 400 mg film-coated tablets imatinib
Hæmolytisk anæmi, trombotisk mikroangiopati 
Haemolytic anaemia, thrombotic microangiopathy Metabolism and nutrition disorders Common
Imatinib Teva 100 mg filmovertrukne tabletter imatinib 
Imatinib Teva 100 mg film-coated tablets imatinib
Imatinib Teva 400 mg filmovertrukne tabletter findes i pakninger med 30 eller 90 filmovertrukne tabletter i blisterpakninger. 
Imatinib Teva 400 mg film-coated tablets are available in pack sizes of 30 or 90 film-coated tablets in blisters.
Startdosis er 400 mg, som skal tages som 4 tabletter én gang daglig. 
The starting dose is 400 mg, to be taken as 4 tablets once a day.
Startdosis er 400 mg, som skal tages som 4 kapsler én gang daglig. 
The starting dose is 400 mg, to be taken as 4 capsules once a day.
EU/1/12/808/001 20 x 1 filmovertrukne tabletter EU/1/12/808/002 60 filmovertrukne tabletter EU/1/12/808/003 60 x 1 filmovertrukne tabletter EU/1/12/808/004 120 filmovertrukne tabletter EU/1/12/808/005 120 x 1 filmovertrukne tabletter EU/1/12/808/006 180 x 1 filmovertrukne tabletter EU/1/12/808/007 20 x 1 filmovertrukne tabletter EU/1/12/808/008 60 filmovertrukne tabletter EU/1/12/808/009 60 x 1 filmovertrukne tabletter EU/1/12/808/010 120 filmovertrukne tabletter EU/1/12/808/011 120 x 1 filmovertrukne tabletter EU/1/12/808/012 180 x 1 filmovertrukne tabletter 
EU/1/12/808/001 20 x 1 film-coated tablets EU/1/12/808/002 60 film-coated tablets EU/1/12/808/003 60 x 1 film-coated tablets EU/1/12/808/004 120 film-coated tablets EU/1/12/808/005 120 x 1 film-coated tablets EU/1/12/808/006 180 x 1 film-coated tablets EU/1/12/808/007 20 x 1 film-coated tablets EU/1/12/808/008 60 film-coated tablets EU/1/12/808/009 60 x 1 film-coated tablets EU/1/12/808/010 120 film-coated tablets EU/1/12/808/011 120 x 1 film-coated tablets EU/1/12/808/012 180 x 1 film-coated tablets
Aktivt stof: imatinib (som mesilat). 
What Imatinib Teva contains - The active substance is imatinib (as mesilate).
EU/1/12/808/013 30 filmovertrukne tabletter EU/1/12/808/014 30 x 1 filmovertrukne tabletter EU/1/12/808/015 90 filmovertrukne tabletter EU/1/12/808/016 90 x 1 filmovertrukne tabletter EU/1/12/808/017 30 filmovertrukne tabletter EU/1/12/808/018 30 x 1 filmovertrukne tabletter EU/1/12/808/019 90 filmovertrukne tabletter EU/1/12/808/020 90 x 1 filmovertrukne tabletter 
EU/1/12/808/013 30 film-coated tablets EU/1/12/808/014 30 x 1 film-coated tablets EU/1/12/808/015 90 film-coated tablets EU/1/12/808/016 90 x 1 film-coated tablets EU/1/12/808/017 30 film-coated tablets EU/1/12/808/018 30 x 1 film-coated tablets EU/1/12/808/019 90 film-coated tablets EU/1/12/808/020 90 x 1 film-coated tablets
Startdosis er 100 mg, som skal tages som 1 tablet á 100 mg én gang daglig. 
The starting dose is 100 mg, to be taken as 1 tablet of 100 mg once a day.
Daunorubicin 30 mg/m2 i.v., dag 1-3, 15-16; 
Daunorubicin 45 mg/m2 i.v., days 6-7, 13-14
Startdosis er 100 mg, som skal tages som 1 kapsel á 100 mg én gang daglig. 
The starting dose is 100 mg, to be taken as 1 capsule of 100 mg once a day.